News

FDA Accepts Bio-Thera Solutions’ Biologics License Application for BAT1706, a Proposed Biosimilar to Avastin®

By EsqSocial Corporation 01/02/21

On January 28, 2021, Bio-Thera Solutions announced that the Food and Drug Administration (FDA) accepted its Biologics License Application (BLA) for BAT1706, a proposed biosimilar to Avastin® (bevacizumab).

Insurer Entitled to Rescind Due to Misrepresentations on Application

By EsqSocial Corporation 01/02/21

The United States District Court for the Central District of California, applying California law, has ruled that an insurer could rescind a policy issued after a homeowners association falsely claimed in its application that it had not had any claims against it in the prior five years.

2021 Biosimilar Approval and Litigation Update

By EsqSocial Corporation 01/02/21

The last two years saw the launch of several biosimilars.  Looking ahead to 2021, several others may be on the horizon.  In 2019-2020, the FDA approved thirteen biosimilars directed to seven reference products.  Eight of the approved biosimilars have launched, while five are either embroiled in l

Four Simple Steps to Prepare for IR35

By EsqSocial Corporation 01/02/21

With everything else going on, it is important not to forget that changes to the off-payroll working rules (commonly known as IR35) are due to come into effect on 6 April 2021, imposing new legal obligations on businesses that engage contractors via personal service companies.

Labor and Employment Update for 2021

By EsqSocial Corporation 01/02/21

On January 27, 2021, our Labor & Employment Group hosted their virtual 2021 seminar highlighting recent developments in labor and employment law.

Biden Administration Seeking Big Changes to “Made in America” Requirements

By EsqSocial Corporation 01/02/21

On January 25, 2021, President Biden signed an Executive Order, titled “Executive Order on Ensuring the Future Is Made in All of America by All of America’s Workers,” aimed at strengthening domestic manufacturing and increasing transparency in procurement for federal contracts.

Texas M&A Trends – Fourth Quarter 2020

By EsqSocial Corporation 01/02/21

BakerHostetler will present data regarding Texas’ robust M&A market each quarter, with useful comparisons to the U.S. market overall. The alert focuses on M&A volume and value, identifies the most active industries, and includes market commentary from our Texas-based M&A attorneys.

Health Cost Transparency and the No Surprise Act: What Employers Need to Know

By EsqSocial Corporation 01/02/21

Starting January 1, 2022, the No Surprise Act will serve to protect patients from surprise medical bills from providers elected under employer health plans by putting the burden of negotiating surprise bills between the provider and the plan.

OEHHA Proposes New Rules for Businesses Using Proposition 65's Short-Form Warnings

By EsqSocial Corporation 01/02/21

This month, the Office of Environmental Health Hazard Assessment (OEHHA) proposed substantial changes to Proposition 65’s short-form warning requirements....
By: Davis Wright Tremaine LLP

New Jersey Creates an extended Covid Open Enrollment Period

By EsqSocial Corporation 01/02/21

The New Jersey Department of Banking and Insurance (“Department”) extended open enrollment and to create an extended COVID-19 Special Enrollment Period (“SEP”) to be in effect beginning at the end of the annual open enrollment period, on February 1, 2021 and extending through May 15, 2021.

Pages